Basic Information
SYNERRV CELECOXIB HARD CAPSULES 100MG
CAPSULE
Regulatory Information
SIN16253P
June 29, 2021
Prescription Only
Therapeutic
ORAL
August 10, 2023
June 3, 2025
XM01AH01
Company Information
Active Ingredients
Strength: 100.00MG
Detailed Information
Contraindications
**CONTRAINDICATION:** Celecoxib is contraindicated in: - Patients with known hypersensitivity to celecoxib or any other ingredient of the product (see List of excipients – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_). - Patients with known sulfonamide hypersensitivity. - Patients with active peptic ulceration or gastrointestinal (GI) bleeding. - Patients who have experienced asthma, urticaria or allergic-type reactions after taking acetylsalicylic acid (ASA \[aspirin\]) or other non-steroidal anti-inflammatory drugs (NSAIDs), including other cyclooxygenase-2 (COX-2) specific inhibitors. - Treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery (see Special warnings and precautions for use). - Congestive heart failure (NYHA II–IV). - Established ischaemic heart disease, peripheral arterial disease and/or cerebrovascular disease.
Indication Information
**INDICATION:** - Symptomatic treatment of osteoarthritis (OA) and rheumatoid arthritis (RA). - Management of acute pain in adults. - Treatment of primary dysmenorrhoea. - Relief of signs and symptoms of ankylosing spondylitis (AS). - Management of chronic low back pain. The decision to prescribe a selective COX-2 inhibitor should be based on an assessment of the individual patient’s overall risks, taking into consideration other available therapeutic options.